Small-Cap REIT ETF ...
Health Care: Drugs
Cubist Pharmaceuticals Inc. (CBST: NASDAQ)
$49.51 0.88 | 1.81%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 104.04M | 197.62M | 372.97M | 157.32M |
| Receivables | 93.47M | 87.80M | 61.20M | 57.83M |
| Inventories | 41.95M | 34.89M | 23.82M | 25.50M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1.16B | 1.04B | 1.02B | 450.03M |
| Property, Plant & Equipment, Gross | 229.99M | 225.58M | 138.68M | 116.38M |
| Accumulated Depreciation & Depletion | 63.53M | 57.16M | 56.25M | 48.00M |
| Property, Plant & Equipment, Net | 166.46M | 168.42M | 82.43M | 68.38M |
| Intangibles | 152.83M | 174.98M | 207.84M | 210.78M |
| Other Non-Current Assets | 341.91M | 378.64M | 47.18M | 185.46M |
| Total Non-Current Assets | 775.34M | 844.18M | 398.91M | 527.65M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 1.93B | 1.89B | 1.42B | 977.68M |
| Accounts Payable | 45.60M | 32.58M | 23.48M | 18.66M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 42.50M | 71.00M | 30.99M | 20.00M |
| Total Current Liabilities | 258.52M | 252.38M | 150.64M | 126.21M |
| Long Term Debt | 367.81M | 454.25M | 435.80M | 245.39M |
| Deferred Income Taxes | 103.08M | 143.18M | 82.83M | 31.20M |
| Other Non-Current Liabilities | 212.23M | 237.79M | 82.46M | 104.23M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 683.12M | 835.21M | 601.09M | 380.82M |
| Total Liabilities | 941.64M | 1.09B | 751.73M | 507.03M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 990.75M | 799.86M | 663.42M | 470.64M |
| Common Par | 65.00K | 63.00K | 59.00K | 0.00 |
| Additional Paid In Capital | 940.97M | 904.28M | 800.62M | 702.25M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | 49.77M | -104.30M | -137.32M | -238.98M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -59.00K | -185.00K | 71.00K | 7.38M |
| Total Capitalization | 1.36B | 1.25B | 1.10B | 716.03M |
| Total Equity | 990.75M | 799.86M | 663.42M | 470.64M |
| Total Liabilities & Stock Equity | 1.93B | 1.89B | 1.42B | 977.68M |
| Total Common Shares Outstanding | 64.71M | 62.64M | 59.34M | 57.98M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 63.77M | 60.84M | 58.80M | 57.75M |
| Diluted Weighted Shares Outstanding | 81.44M | 62.94M | 62.66M | 68.38M |
| Number of Employees | 762 | 669 | 638 | 600 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CBST
- Portfolio NameUser Type
- ContributorGARP Growers for Summer 2013
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 6
- ContributorStocks At New 52-Week Highs...
- ContributorTop-Rated Biotechnology Stocks
- ContributorEarnings Short Squeeze Play...
- ContributorStocks At New 52-Week Highs...
Latest CBST Headlines from TheStreet
- Cubist Rises On Unusually High Volume (CBST) 04.02.13 | 04:04 pm
- 'Mad Money' Lightning Round: Solar Capital Is a Winner 03.08.13 | 06:03 am
- Cramer's 'Mad Money' Recap: Follow the Market Leaders 03.07.13 | 08:03 pm
- 5 Stocks Set to Soar on Bullish Earnings 01.22.13 | 02:01 pm
- FDA Places New Heart-Safety Hurdle in Path of Opioid Constipation Drugs 11.12.12 | 10:11 am
- Cubist Stock Hits New 52-Week High (CBST) 09.21.12 | 03:09 pm
- Cramer's 'Mad Money' Recap: When Progress Isn't Good 09.18.12 | 08:09 pm
- Cubist Stock Hits New 52-Week High (CBST) 09.13.12 | 02:09 pm
- Nektar Therapeutics Is a Short 09.12.12 | 07:09 am
- Cubist Reaches New 52-Week High (CBST) 09.04.12 | 01:09 pm
Press Releases for CBST
- Cubist Obtains Remaining Rights To Ceftolozane From Astellas - Business Wire 03.11.13 | 08:03 am
- Michael Tomsicek, Cubist CFO (Photo: Business Wire) - Business Wire 03.04.13 | 07:03 am
- FDA Grants QIDP And Fast Track Designations For Cubist’s Late-Stage Antibiotic Candidates - Business Wire 02.28.13 | 04:02 pm
- Cubist Pharmaceuticals To Present At Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.27.13 | 08:02 am
- Cubist Announces Exclusive Option To Acquire Adynxx - Business Wire 02.25.13 | 08:02 am
- Cubist To Present At February Investor Conferences - Business Wire 01.29.13 | 08:01 am
- Cubist Reports Fourth Quarter And Full Year 2012 Financial Results - Business Wire 01.23.13 | 04:01 pm
- Thomas J. DesRosier (Photo: Business Wire) - Business Wire 01.08.13 | 08:01 am
- Cubist Announces Full-Year 2012 Revenues And Provides Business Update - Business Wire 01.07.13 | 07:01 am
- Heptares Partners With Cubist To Research New Medicines Targeting GPCRs - PR Newswire 01.07.13 | 07:01 am
Partner Headlines for CBST
- Jump On Board With These 2 Companies - Seeking Alpha 04.22.13 | 09:04 am
- Revenues Decline at Alnylam - Analyst Blog - Zacks 11.07.12 | 09:11 am
- Narrower Loss at Optimer - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- Pipeline Progress at Cubist Pharma - Analyst Blog - Zacks 11.01.12 | 06:11 pm
- Stocks Tumble On Disappointing Earnings Reports - Investor's Business Daily 10.19.12 | 04:10 pm
- Stocks Hit Fresh Intraday Lows; Google Reverses Lower - Investor's Business Daily 10.19.12 | 03:10 pm
- Stocks Headed For Weaker Start; Polaris Motors Up - Investor's Business Daily 10.18.12 | 09:10 am
- After-Hours Earnings Report for October 18, 2012 : MSFT, GOOG, COF, SNDK, CMG, PBCT, FLEX, RHI, VMI, RVBD, CYT, CBST - NASDAQ 10.18.12 | 04:10 am
- After-Hours Earnings Report for October 18, 2012 : MSFT, GOOG, COF, SNDK, CMG, PBCT, FLEX, RHI, VMI, RVBD, CYT, CBST - NASDAQ 10.18.12 | 04:10 am
- Stocks Mixed In Afternoon Trade; Homebuilders Lead - Investor's Business Daily 10.17.12 | 01:10 pm
